In vivo base editing partially rescues bone dysplasia in a mouse model of Hutchinson-Gilford Progeria Syndrome
RNA-seq (gene expression) · mouse · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE334271_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1474460 and SRA study SRP706563. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9784318 599M_WT_WT
- GSM9784319 600M_WT_WT
- GSM9784320 601F_WT_WT
- GSM9784321 602F_WT_WT
- GSM9784322 603F_WT_WT
- GSM9784323 604F_WT_WT
- GSM9784324 606M_WT_WT
- GSM9784325 608M_WT_WT
- GSM9784326 611F_WT_WT
- GSM9784327 615M_WT_WT
- GSM9784328 617M_WT_WT
- GSM9784329 619F_WT_WT
- GSM9784330 F109420_saline
- GSM9784331 F109436_ABE
- GSM9784332 F109466_saline
- GSM9784333 F1WT609535_ABE
- GSM9784334 F209536_saline
- GSM9784335 F309418_saline
- GSM9784336 F309422_saline
- GSM9784337 F309431_ABE
- GSM9784338 F309468_ABE
- GSM9784339 F409439_saline
- GSM9784340 F509471_ABE
- GSM9784341 F609472_ABE
- GSM9784342 M109432_saline
- GSM9784343 M109440_saline
- GSM9784344 M109455_ABE
- GSM9784345 M109464_ABE
- GSM9784346 M1WT509424_saline
- GSM9784347 M209511_saline
- GSM9784348 M309451_saline
- GSM9784349 M309457_ABE
- GSM9784350 M409446_saline
- GSM9784351 M409458_ABE
- GSM9784352 M4WT109560_ABE
- GSM9784353 M509459_ABE
- GSE263775 Small molecule inhibition rescues the skeletal dysplasia phenotype of Trpv4 mutant mice 5 samples shares dysplasia, rescues
- GSE315211 Bulk RNA-seq of multiple organs in LmnaG609G progeria mice with inducible Δ133p53α 99 samples shares progeria
- GSE264350 Disruption of the Circadian Rhythm Is Exacerbated by Aging and Partially Restored by Time-restricted Feeding 78 samples shares partially
- GSE283659 Skeletal dysplasia-causing mutations in TRPV4 alter the chondrocyte’s transcriptomic response to mechanical loading 71 samples shares dysplasia
- GSE223847 CMS121 partially attenuates disease progression in mouse models of Huntington's disease 22 samples shares partially
- GSE306148 Fucci-G1 insertion partially disrupts Shh expression 18 samples shares partially
- GSE260706 Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation 16 samples shares partially
- GSE298723 Rapamycin, but not propranolol, can partially revert CCM phenotype in brain endothelial cells and ameliorates chronic cavernoma development in combination with lapatinib 16 samples shares partially
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.